source
- Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded marketNine midsize biopharma companies have agreed to voluntarily participate in the Trump administration's Most Favored Nation drug pricing program, adding to the 17 large pharmaceutical firms that prev…
- Arsenal Biosciences cuts 99 jobs as it pivots to in vivo CAR-T therapyArsenal Biosciences announced another round of layoffs, eliminating 99 positions, which represents the majority of its workforce after a prior 50% reduction last year. The cuts are part of a strat…